Tadalista Super Active, like other tadalafil-based medications, affects blood flow and can potentially interact with anesthesia or medications used during surgery. Generally, it is recommended to stop taking Tadalista Super Active at least 48 to 72 hours before any planned surgery. This window allows the drug to clear from the body, reducing the risk of complications such as hypotension (low blood pressure) when combined with anesthetics or nitrates that might be administered perioperatively. Patients should also inform their surgeon and anesthesiologist about any recent use of Tadalista Super Active. Individual factors such as kidney or liver function, age, and cardiovascular health may affect how long the drug remains active, so a personalized recommendation from a doctor is essential. Adhering to this guidance helps ensure safer surgery and anesthesia outcomes.